Researchers at the Icahn School of Medicine at Mount Sinai have unveiled a game-changing computational tool called LoGoFunc, designed to predict pathogenic gain- and loss-of-function variants within the human genome. Unlike existing methods that primarily focus on loss of function, LoGoFunc’s revolutionary approach distinguishes between different harmful mutations, promising crucial insights into diverse disease outcomes.